RAMELLA, SARA
 Distribuzione geografica
Continente #
AS - Asia 9.911
NA - Nord America 1.359
EU - Europa 1.190
SA - Sud America 318
AF - Africa 47
OC - Oceania 15
Totale 12.840
Nazione #
SG - Singapore 8.318
US - Stati Uniti d'America 1.283
CN - Cina 775
HK - Hong Kong 519
IT - Italia 491
BR - Brasile 257
GB - Regno Unito 200
DE - Germania 164
VN - Vietnam 138
NL - Olanda 87
EE - Estonia 57
FI - Finlandia 49
IN - India 48
CA - Canada 43
ZA - Sudafrica 25
ID - Indonesia 24
AR - Argentina 23
MX - Messico 21
TR - Turchia 18
UA - Ucraina 18
EC - Ecuador 15
FR - Francia 15
SE - Svezia 15
AT - Austria 14
CZ - Repubblica Ceca 14
JP - Giappone 14
AU - Australia 12
BD - Bangladesh 11
ES - Italia 11
PL - Polonia 11
RO - Romania 8
CO - Colombia 6
IQ - Iraq 6
CH - Svizzera 5
CL - Cile 5
LT - Lituania 5
PE - Perù 5
RU - Federazione Russa 5
TW - Taiwan 5
EG - Egitto 4
BE - Belgio 3
KZ - Kazakistan 3
PH - Filippine 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UZ - Uzbekistan 3
AF - Afghanistan, Repubblica islamica di 2
BG - Bulgaria 2
CM - Camerun 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
MA - Marocco 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KI - Kiribati 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SL - Sierra Leone 1
Totale 12.832
Città #
Singapore 539
Hong Kong 453
Hefei 396
Ashburn 269
Dallas 210
Boardman 195
London 170
Beijing 149
Rome 147
Shanghai 137
Munich 103
Council Bluffs 60
Ho Chi Minh City 58
Los Angeles 57
Amsterdam 38
San Francisco 36
Hanoi 30
Turku 28
Pune 26
Washington 26
Seattle 25
Milan 23
São Paulo 22
Helsinki 21
Naples 21
Toronto 21
Chicago 19
Santa Clara 17
Brooklyn 15
New York 14
Boston 12
Brno 12
Atlanta 11
Sona 11
Johannesburg 10
Mexico City 10
Stockholm 10
Warsaw 10
West Jordan 10
Palermo 9
Tokyo 9
Bologna 8
Charlotte 8
Rio de Janeiro 8
Florence 7
Manaus 7
Montreal 7
Nuremberg 7
Phoenix 7
Quito 7
Ankara 6
Biên Hòa 6
Hanover 6
Redmond 6
Buffalo 5
Chennai 5
Da Nang 5
Denver 5
Frankfurt am Main 5
Lima 5
Melbourne 5
Rocca di Papa 5
Santo André 5
Vicenza 5
Brasília 4
Cascina 4
Curitiba 4
Guangzhou 4
Guarulhos 4
Guayaquil 4
Haikou 4
Haiphong 4
Jakarta 4
Manchester 4
Ninh Bình 4
Porto Alegre 4
Providence 4
Salvador 4
Umeå 4
Andover 3
Aprilia 3
Bangkok 3
Baoding 3
Belo Horizonte 3
Bergamo 3
Bogotá 3
Buenos Aires 3
Canberra 3
Castelfranco Veneto 3
Central 3
Charleston 3
Gravina di Catania 3
Handan 3
Hải Dương 3
Lucca 3
Manila 3
Markham 3
New Delhi 3
Petrópolis 3
Resistencia 3
Totale 3.702
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 296
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 278
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 240
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 226
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 211
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 205
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 205
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 205
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 200
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 199
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 197
Exploring Deep Pathomics in Lung Cancer 196
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 192
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 191
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 191
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 189
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 189
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 189
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 186
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 186
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 186
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 185
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 185
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 184
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 183
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 183
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 180
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 178
Preventing Cardiotoxicity in Personalized Breast Irradiation 174
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 173
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 169
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 137
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 124
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 109
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 107
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 106
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 104
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 103
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 101
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 101
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 101
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 100
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 100
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 99
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 99
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 99
MR imaging of rectal cancer before and after chemoradiation therapy 99
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 98
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 98
Evaluating GANs in Medical Imaging 96
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 94
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 94
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 93
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 93
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 92
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 91
A deep learning approach for overall survival prediction in lung cancer with missing values 90
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 89
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 87
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 86
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 85
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 83
Chemoradiation for stage III non-small cell lung cancer 83
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 83
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 82
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 80
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 75
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 71
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 69
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 68
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 68
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 65
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 63
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 43
Precision radiotherapy by SPECT lung functional imaging in NSCLC 41
Protective Role of Natural Compounds under Radiation-Induced Injury 38
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 37
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 34
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 34
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 34
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 33
Evidence-Based Radiotherapy: “Hot Topics” 2010 NSCLC 33
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. 32
Radiation therapy of breast cancer. Reasoned approach to a clinical case 32
Il trattamento radioterapico del Mesotelioma Pleurico 32
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 32
Gemcitabine and radiotherapy 31
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 30
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 30
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 29
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report. 29
Stage III NSCLC treatment options: too many choices 28
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 28
Radiation Therapy in management of malignant pleural mesothelioma: Pros (2). 28
The first survey on defensive medicine in radiation oncology 28
Neoadjuvant chemoradiotherapy followed by surgery in elderly patients with locally advanced Non-Small Cell Lung Cancer: Analysis of feasibility, toxicity and factors predicting surgical resection and survival. 28
Role of PSA levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy 27
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. 27
Locally advanced NSCLC: how to improve disease control? 27
Multimodality treatment in locally advanced non-small cell lung cancer 27
Totale 10.868
Categoria #
all - tutte 77.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.583


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 6 6 5 1 3 6 6 13 7 0 168
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024592 21 62 36 35 60 251 14 36 4 22 11 40
2024/20259.995 96 48 221 64 113 219 153 34 522 725 3.591 4.209
2025/20261.976 614 325 483 554 0 0 0 0 0 0 0 0
Totale 12.956